
The FY2027 appropriations process gives Congress an immediate opportunity to protect medical cannabis patients from discrimination while addressing the gaps left by the Attorney General's order. Through funding directives, legislative provisions, and committee report language, Congress can require federal agencies to protect patients, update outdated policies, and establish the safeguards necessary for safe access and healthcare integration. These actions cannot replace comprehensive medical cannabis legislation, but they can help ensure that patients are not left behind while Congress develops a national framework.
For ASA's complete appropriations agenda, detailed requests across all seven subcommittees, and the latest congressional developments, visit our FY2027 Medical Cannabis Appropriations Hub. The hub will be updated as Congress considers FY2027 funding legislation and patient advocacy opportunities.
DOWNLOAD PROPOSED VA APPROPS LANGUAGE | TAKE ACTION
WHY THE VETERANS AFFAIRS SUBCOMMITTEE MUST ACT
The Military Construction, Veterans Affairs, and Related Agencies Subcommittee can help close the gap between federal recognition of medical cannabis and the healthcare available to veterans. Qualifying medical cannabis products received different federal scheduling treatment under Attorney General Order No. 6754-2026, but that order did not automatically replace VA clinical policies or establish a national medical cannabis program. Veterans participating in state-authorized medical cannabis programs cannot be denied Veterans Health Administration (VHA) services solely because of that participation, yet they continue to face barriers to receiving state-program assistance from the clinicians who know their medical histories.
VHA Directive 1315, revised in July 2023, already instructs VA clinicians to discuss relevant clinical information about cannabis and document it in veterans' electronic health records. It nevertheless prohibits those clinicians from recommending medical cannabis, referring veterans for state program participation, completing state forms, or registering veterans. That separation can leave veterans seeking qualifying recommendations and paperwork from clinicians outside their VA care teams, complicating medication-interaction screening, treatment planning, and continuity of care.
The American Legion reports that approximately 22% of veterans currently use cannabis to treat medical conditions, 40% of caregivers know a veteran who uses medical cannabis for symptom relief, and 82% of veterans want to have medical cannabis as a federally legal treatment option. Many veterans find medical cannabis beneficial for managing PTSD, chronic pain, other service-related health issues, and all the other conditions that civilians use cannabis to treat. However, federal restrictions significantly limit their access. Although advocates have successfully removed the risk of losing VA benefits for veterans enrolled in state medical cannabis programs, Veterans who need cannabis medicines are on their own.
ASA'S FY2027 APPROPRIATIONS REQUEST |
The Military Construction and Veterans Affairs Subcommittee can help close the gap between federal recognition of medical cannabis and the healthcare available to veterans. Although veterans may participate in state medical cannabis programs without automatically losing VA benefits, existing VHA policies prevent VA clinicians from recommending cannabis medicines or completing state program forms, often leaving patients to seek treatment guidance outside their primary healthcare system. Congress should direct VA to replace VHA Directive 1315, establish appropriate clinical support and documentation standards, and evaluate the patient safety, healthcare costs, and implementation needs associated with integrating state-authorized medical cannabis into veterans’ care.
ASA also requests a distinct electronic health record field for therapeutic medical cannabis consumption, with clinically relevant information about formulations, dose, route, possible interactions, and care coordination. VA should provide system-wide training, review inaccurate historical classifications where correction is warranted, and study clinical protocols, implementation costs, potential savings, veteran safety, and continuity of care. These measures do not direct VA to dispense unapproved products or assume existing federal law authorizes VA reimbursement for state medical cannabis purchases.

A. VA CLINICAL SUPPORT FOR VETERANS PARTICIPATING IN STATE MEDICAL CANNABIS PROGRAMS
“VA health care providers are prohibited from recommending, making referrals to, completing forms, or registering Veterans for participation in a State-approved marijuana program. AUTHORITY: 38 U.S.C. § 7301(b)-”Access to VHA Clinical Programs for Veterans Participating in State- Approved Marijuana Programs (111 KB, PDF).” (VHA Directive 1315)
For veterans relying solely on the Veterans Health Administration (VHA) for healthcare, their providers are prohibited from recommending medical cannabis. As a result, veterans must pay out-of-pocket not only for cannabis treatments and state ID card fees but also for consultations with cannabis specialists. Veterans unable to afford these expenses often turn to adult-use markets without medical oversight, unregulated hemp-derived products, or the illicit market. 22% of Veterans report using medical cannabis; VHA medical professionals should have more tools to serve them, and the VA should be learning more from the Veterans’ experiences.
For more than fifteen years, advocates have sought to allow Veterans Health Administration (VHA) providers to recommend medical cannabis and assist veterans with state program enrollment. Although such language appeared in both the House and Senate versions of the Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026, H.R. 3944 SEC 421, it was removed from the final H.R. 5371 package FY2026.
ASA Request: Direct the VA to replace VHA Directive 1315 and allow VA clinicians to support veterans participating in state medical cannabis programs, including by discussing medical cannabis, documenting therapeutic use, making referrals, completing state forms, and assisting with registration where consistent with state law and clinical judgment.
Purpose: Veterans who rely on VA healthcare are forced to seek medical cannabis guidance outside the VA system, often from clinicians without access to their full medical history, medication list, disability profile, or treatment plan.
PROPOSED BILL LANGUAGE:
SEC. __. VA CLINICAL SUPPORT FOR STATE MEDICAL CANNABIS PROGRAM PARTICIPATION. Not later than 30 days after the date of enactment of this Act, the Secretary of Veterans Affairs shall issue guidance permitting Department of Veterans Affairs healthcare providers to discuss medical cannabis with veterans and, where consistent with state law and clinical judgment, recommend medical cannabis, make referrals, complete state medical cannabis program forms, assist veterans in registering for state-authorized medical cannabis programs, document therapeutic medical cannabis use, evaluate potential drug interactions, and coordinate care.
B. VA ELECTRONIC MEDICAL RECORD CODE FOR THERAPEUTIC USE OF CANNABIS
ASA Request: Direct VA to update its electronic medical record systems to include a distinct code or field for therapeutic medical cannabis use.
Purpose: Medical cannabis use should be documented as therapeutic medication use when appropriate, not automatically recorded as non-medical use, illicit drug use, or substance-use-disorder-related history.
PROPOSED COMMITTEE REPORT LANGUAGE:
VHA Medical Cannabis Documentation and Report. The Committee directs VA to report on potential cost savings, clinical protocols, patient safety guidance, education needs, and implementation requirements associated with allowing VHA clinicians to support veterans participating in state medical cannabis programs.
PROPOSED BILL LANGUAGE:
SEC. __. VHA MEDICAL CANNABIS DOCUMENTATION & REPORT. The Secretary of Veterans Affairs shall update Department electronic medical record systems to include a distinct code or field for therapeutic medical cannabis use, separate from non-medical cannabis use, illicit drug use, or substance-use- disorder-related documentation. Such documentation shall include, where known, the route of administration, cannabinoid content, dose, frequency of use, participation in a state medical cannabis program, the certifying healthcare professional, where applicable, possible drug interactions, contraindications, and care-coordination needs.
Not later than 1 year after the date of enactment of this Act, the Secretary shall submit to the Committees on Appropriations a report evaluating cost savings, clinical protocols, education requirements, and implementation needs for VHA medical cannabis clinical support.
DOWNLOAD PROPOSED VA APPROPS LANGUAGE
THE PATH FORWARD |
The priorities outlined here are part of Americans for Safe Access' coordinated FY2027 appropriations agenda across seven congressional subcommittees. Together, these requests seek to protect patients, remove discriminatory barriers, strengthen federal accountability, and establish the policies necessary to integrate medical cannabis into American healthcare.
Congress can take meaningful action through the appropriations process while laying the groundwork for comprehensive medical cannabis legislation in the 120th Congress. Patients should not have to choose between the medicine they rely on and their healthcare, housing, livelihoods, or fundamental rights. Explore ASA's complete FY2027 Medical Cannabis Appropriations Agenda to learn how these requests work together and follow the latest congressional developments.
The Path Forward: The Medical Cannabis & Cannabinoid Act
References & SourcesDEA Marijuana Rescheduling Regulatory Actions Veterans Health Administration, VHA Directive 1315, July 28, 2023. Access to VHA Clinical Programs for Veterans Participating in State-Approved Marijuana Programs. U.S. Department of Veterans Affairs, VA and Marijuana: What Veterans Need to Know. VA Public Health Guidance. House-passed FY2027 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, H.R. 8469, Section 420, May 15, 2026. House-passed Legislative Text. Senate FY2027 Military Construction, Veterans Affairs, and Related Agencies Appropriations Draft, released November 10, 2026. Senate Draft Bill and Senate Explanatory Statement. Attorney General Order No. 6754-2026, Federal Register, April 28, 2026, 91 FR 22714. Schedules of Controlled Substances: Rescheduling of FDA-Approved Products Containing Marijuana. 38 U.S.C. § 7301(b), Functions of the Veterans Health Administration. United States Code. Veterans Health Administration, VHA Directive 1345, Medication Reconciliation, March 9, 2022. VA Medication Reconciliation Policy. Veterans Health Administration, VHA Directive 1164, Essential Medication Information, July 13, 2023. VA Essential Medication Information Policy. Congressional Research Service, Department of Justice Eases Control of Medical Marijuana, April 30, 2026, LSB11424. CRS Legal Analysis. The American Legion, Survey Shows Veteran Households Support Research of Medical Cannabis, November 2017. American Legion Survey Results. |
Share this page